Latest News about BIIB
Recent news which mentions BIIB
Deal Dispatch: Biden Punts TikTok Ban To Trump, Plus Another Legacy Retailer Goes Bankrupt
January 17, 2025
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 14, 2025
From Benzinga
FDA To Review Under the Skin Weekly Autoinjector For Biogen/Eisai's Alzheimer's Drug Leqembi
January 14, 2025
From Benzinga
From Benzinga
Crude Oil Surges 3%; Abercrombie & Fitch Shares Plunge
January 13, 2025
From Benzinga
Intra-Cellular Therapies, Standard BioTools, SI-BONE And Other Big Stocks Moving Higher On Monday
January 13, 2025
From Benzinga
From Benzinga
Enduring Truths for Investors Both New and Seasoned
January 11, 2025
From Motley Fool
Denali Therapeutics' Amyotrophic Lateral Sclerosis Misses Pivotal Trial, But Analyst Says It Was Expected
January 07, 2025
From Benzinga
These Were the 5 Worst-Performing Stocks in the Nasdaq-100 in 2024
January 04, 2025
From Motley Fool
From Benzinga
From Benzinga
Super Micro Computer Teeters On Edge Of Nasdaq 100: Can xAI, Nvidia Help Stabilize Trajectory?
December 11, 2024
From Benzinga
Biogen Downgraded On Pipeline Setbacks And Leqembi Sales Slowdown
December 09, 2024
From Benzinga
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
December 02, 2024
From Benzinga
From Motley Fool
Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside
November 20, 2024
From Benzinga
Biogen's Outlook Dims As Analyst Projects Flat Revenue Until 2026
November 18, 2024
From Benzinga
From Benzinga
Disney To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Friday
November 15, 2024
From Benzinga
Peeling Back The Layers: Exploring Biogen Through Analyst Insights
November 14, 2024
Tickers
BIIB
From Benzinga
Biogen Analysts Slash Their Forecasts After Q3 Results
October 31, 2024
From Benzinga
This Kraft Heinz Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
October 31, 2024
From Benzinga
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
October 30, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.